4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
4d Molecular Therapeutics, Inc. shareholders
As of Jun 30, 2026, 151 institutions reported holding 4d Molecular Therapeutics, Inc. Largest: Jupiter Topco LLC, Ra Capital Management, L.P. and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of 4d Molecular Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Jupiter Topco LLC | 5.75M | first report | Aug 14, 2026 | |
| Ra Capital Management, L.P. | 5.05M | no change | Aug 14, 2026 | |
| BlackRock | 4.55M | +401K | Aug 7, 2026 | |
| Goldman Sachs | 4.26M | +53,230 | Aug 14, 2026 | |
| Novo Holdings A/S | 3.25M | −402K | Aug 14, 2026 | |
| Vanguard | 2.97M | −82,670 | Aug 13, 2026 | |
| State Street | 2.91M | +203K | Aug 7, 2026 | |
| Bvf Inc | 2.88M | no change | Aug 14, 2026 | |
| T. Rowe Price | 2.57M | +2.52M | Aug 14, 2026 | |
| Adage Capital Partners Gp, L.L.C. | 2.25M | +644K | Aug 14, 2026 |